|
miR
|
Role in neuroinflammation, neuroprotection, neurodegeneration, and cognition
|
| miR-106b-5p |
Upregulated during neuroinflammation and neurodegenerative disease models [105–109] |
| miR-15a-5p |
Can have pro- or anti-apoptotic activity [53, 54, 110] |
| miR-15b-5p |
Can have pro- or anti-apoptotic activity [110–113] |
| miR-190a-3p |
Biomarker for postoperative cognitive dysfunction [55] |
| miR-212-3p |
Downregulation is a biomarker for neurodegenerative disease [114–116] |
| miR-223-3p |
Inhibition of neuroinflammation [47–49, 117]. Biomarker of sepsis severity [102] |
| miR-30b-5p |
Upregulation is neuroprotective [118–120] |
| miR-30c-5p |
Can have pro- or anti-apoptotic activity [121–123] |
| miR-31-3p |
Role in conditioned place preference [124] |
| miR-323-3p |
Biomarker for cognitive impairment [125, 126] |
| miR-33-3p |
Neurogenesis [127] |
| miR-340-5p |
Anti-inflammatory and neuroprotective [128–130] |
| miR-342-3p |
Upregulated in neuroinflammation and neurodegenerative disease models [131–135] |
| miR-362-5p |
Nervous system development [136] |
| miR-381-3p |
Upregulation during encephalomyelitis [137] and HIV associated with cognitive impairment [138] |
| miR-7a-1-3p |
Promotes generation of oligodendrocytes [139] and regulates excitatory synaptic transmission [140] |
| let-7f-1 |
Promotes IL-6 secretion in activated macrophages [141] |
| miR-98-3p |
Upregulated by caloric restriction [142] |